27 June 2024
Analyst Outlook June 2024
Our analysts provide their sector outlook and top stock picks for June 2024.
18 June 2024
Clinuvel Pharmaceuticals (CUV): Looking to Vitiligo
CUV are conducting two Phase 3 trials to expand the label of Scenesse to include patients with vitiligo.
5 June 2024
The cycle appears to be turning
As we move closer to the halfway mark for CY24, the U.S. economy has displayed remarkable resilience, with stocks at near all-time highs and the S&P 500 defying forecasts for a slowdown.
12 April 2024
Regis Resources Ltd (RRL): McPhillamys still stacks up
We have reviewed our valuation of RRL’s 100%-owned McPhillamys Gold Project following the recent update of estimated costs of key elements of the project.